Lee, Paula S <br/><br/>
Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.  [electronic resource] 

 -  International journal of cancer  Mar 2010 
 - 1378-89 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.24797  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Azacitidine--pharmacology<br/>Base Sequence<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cisplatin--pharmacology<br/>DNA Methylation<br/>Drug Resistance, Neoplasm--genetics<br/>Epithelial Cells--pathology<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Membrane Transport Proteins--genetics<br/>Molecular Sequence Data<br/>Myelin Proteins--genetics<br/>Myelin and Lymphocyte-Associated Proteolipid Proteins<br/>Oligonucleotide Array Sequence Analysis<br/>Ovarian Neoplasms--drug therapy<br/>Promoter Regions, Genetic--genetics<br/>Proteolipids--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Sequence Analysis, DNA--methods<br/>Survivors